Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Gibson

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Investigation|September 1, 2023
Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancerJessica M Konen, B Leticia Rodriguez, Haoyi Wu, et al.
Hematology/Oncology and Stem Cell Therapy|December 27, 2011
Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantationAbraham Sebastian Kanate, Michael Craig, Aaron Cumpston, et al.
Molecular Ecology|December 19, 2016
Characterizing human cytomegalovirus reinfection in congenitally infected infants: an evolutionary perspectiveCornelia Pokalyuk, Nicholas Renzette, Kristen K Irwin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2015
Limits and patterns of cytomegalovirus genomic diversity in humansNicholas Renzette, Cornelia Pokalyuk, Laura Gibson, et al.
Cancers|April 17, 2019
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung CancerJessica M Konen, B Leticia Rodriguez, Jared J Fradette, et al.
JMIR Formative Research|August 30, 2022
Feasibility of At-Home Serial Testing Using Over-the-Counter SARS-CoV-2 Tests With a Digital Smartphone App for Assistance: Longitudinal Cohort StudyCarly Herbert, John Broach, William Heetderks, et al.
International Journal of Neonatal Screening|December 22, 2022
Congenital Cytomegalovirus Screening in Massachusetts Birth Hospitals: A Statewide SurveyCheryl K Glovsky, Kendall Carroll, Naomi Clark, et al.
Nature Communications|May 11, 2021
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancersDavid H Peng, B Leticia Rodriguez, Lixia Diao, et al.
Cancer Research|January 6, 2021
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLCJessica M Konen, B Leticia Rodriguez, Aparna Padhye, et al.
IEEE Open Journal of Engineering in Medicine and Biology|June 30, 2021
The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx TechMatthew Robinson, Charlotte Gaydos, Barbara Van Der Pol, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|September 1, 2023
Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancerJessica M Konen, B Leticia Rodriguez, Haoyi Wu, et al.
Hematology/Oncology and Stem Cell Therapy|December 27, 2011
Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantationAbraham Sebastian Kanate, Michael Craig, Aaron Cumpston, et al.
Molecular Ecology|December 19, 2016
Characterizing human cytomegalovirus reinfection in congenitally infected infants: an evolutionary perspectiveCornelia Pokalyuk, Nicholas Renzette, Kristen K Irwin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2015
Limits and patterns of cytomegalovirus genomic diversity in humansNicholas Renzette, Cornelia Pokalyuk, Laura Gibson, et al.
Cancers|April 17, 2019
Ntrk1 Promotes Resistance to PD-1 Checkpoint Blockade in Mesenchymal Kras/p53 Mutant Lung CancerJessica M Konen, B Leticia Rodriguez, Jared J Fradette, et al.
JMIR Formative Research|August 30, 2022
Feasibility of At-Home Serial Testing Using Over-the-Counter SARS-CoV-2 Tests With a Digital Smartphone App for Assistance: Longitudinal Cohort StudyCarly Herbert, John Broach, William Heetderks, et al.
International Journal of Neonatal Screening|December 22, 2022
Congenital Cytomegalovirus Screening in Massachusetts Birth Hospitals: A Statewide SurveyCheryl K Glovsky, Kendall Carroll, Naomi Clark, et al.
Nature Communications|May 11, 2021
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancersDavid H Peng, B Leticia Rodriguez, Lixia Diao, et al.
Cancer Research|January 6, 2021
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLCJessica M Konen, B Leticia Rodriguez, Aparna Padhye, et al.
IEEE Open Journal of Engineering in Medicine and Biology|June 30, 2021
The Clinical Review Committee: Impact of the Development of In Vitro Diagnostic Tests for SARS-CoV-2 Within RADx TechMatthew Robinson, Charlotte Gaydos, Barbara Van Der Pol, et al.
Pageof 8